Skip to main content
. Author manuscript; available in PMC: 2018 Jun 24.
Published in final edited form as: Mol Carcinog. 2011 Mar 3;50(12):913–921. doi: 10.1002/mc.20751

Figure 4.

Figure 4

An additive combined effect of budesonide and pioglitazone in inhibition of cell proliferation of human lung cancer cells. (A) Budesonide inhibits the proliferation of human non-small lung cancer cells in a dose- and time-dependent manner. (B) Combination (Comb) of budesonide (Bud) and pioglitazone (Pio) additively inhibits the proliferation of human non-small lung cancer cells.